SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-032813
Filing Date
2020-05-28
Accepted
2020-05-28 21:18:11
Documents
1
Period of Report
2019-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 6161
  Complete submission text file 0001209191-20-032813.txt   7579
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 325 E. MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address
Keyt Bruce (Reporting) CIK: 0001787362 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39045 | Film No.: 20923823